| Andrew Sumner, AA | |
|
4600 E Sam Houston Pkwy S, Pasadena, TX 77505-3948 | |
| (281) 487-0700 | |
| Not Available |
| Full Name | Andrew Sumner |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 15 Years |
| Location | 4600 E Sam Houston Pkwy S, Pasadena, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467680298 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 959 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi St Luke's Health Baylor College Of Medicine Me | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8022243971 | 917 |
News Archive
Manhattan Pharmaceuticals, Inc. announced that on January 4, 2011, the company entered into a settlement and release agreement with Nordic Biotech Fund II K/S and H Pharmaceuticals K/S. Manhattan Pharmaceuticals and Nordic are partners in the H Pharmaceuticals joint venture for the development and commercialization of Hedrin®, a non-pesticide treatment for head lice.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
"More than 435,000 people have been displaced in Mali, as the country faces a complex humanitarian emergency due to conflict and food insecurity, according to a new report released by the United Nations relief agency," the U.N. News Centre reports.
People with severe stomach disorders can sometimes suffer from chronic vomiting. This symptom can be treated with electrical impulses from a pacemaker in the stomach. A new method enables patients who could benefit from this treatment to be identified, and electrical stimulation leads to reduced nausea and fewer days in hospital, shows a study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
"To E or not to E," a question prompted by a controversial analysis released last week, is addressed by leading researchers and physicians who recommend that Americans keep taking vitamin E supplements in recommended amounts for overall health benefits.
› Verified 9 days ago
| Entity Name | Space City Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235328253 PECOS PAC ID: 8628154416 Enrollment ID: O20080319000229 |
News Archive
Manhattan Pharmaceuticals, Inc. announced that on January 4, 2011, the company entered into a settlement and release agreement with Nordic Biotech Fund II K/S and H Pharmaceuticals K/S. Manhattan Pharmaceuticals and Nordic are partners in the H Pharmaceuticals joint venture for the development and commercialization of Hedrin®, a non-pesticide treatment for head lice.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
"More than 435,000 people have been displaced in Mali, as the country faces a complex humanitarian emergency due to conflict and food insecurity, according to a new report released by the United Nations relief agency," the U.N. News Centre reports.
People with severe stomach disorders can sometimes suffer from chronic vomiting. This symptom can be treated with electrical impulses from a pacemaker in the stomach. A new method enables patients who could benefit from this treatment to be identified, and electrical stimulation leads to reduced nausea and fewer days in hospital, shows a study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
"To E or not to E," a question prompted by a controversial analysis released last week, is addressed by leading researchers and physicians who recommend that Americans keep taking vitamin E supplements in recommended amounts for overall health benefits.
› Verified 9 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
Manhattan Pharmaceuticals, Inc. announced that on January 4, 2011, the company entered into a settlement and release agreement with Nordic Biotech Fund II K/S and H Pharmaceuticals K/S. Manhattan Pharmaceuticals and Nordic are partners in the H Pharmaceuticals joint venture for the development and commercialization of Hedrin®, a non-pesticide treatment for head lice.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
"More than 435,000 people have been displaced in Mali, as the country faces a complex humanitarian emergency due to conflict and food insecurity, according to a new report released by the United Nations relief agency," the U.N. News Centre reports.
People with severe stomach disorders can sometimes suffer from chronic vomiting. This symptom can be treated with electrical impulses from a pacemaker in the stomach. A new method enables patients who could benefit from this treatment to be identified, and electrical stimulation leads to reduced nausea and fewer days in hospital, shows a study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
"To E or not to E," a question prompted by a controversial analysis released last week, is addressed by leading researchers and physicians who recommend that Americans keep taking vitamin E supplements in recommended amounts for overall health benefits.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Sumner, AA 714 Fm 1960 Rd W, Suite 209, Houston, TX 77090-3405 Ph: (281) 880-6991 | Andrew Sumner, AA 4600 E Sam Houston Pkwy S, Pasadena, TX 77505-3948 Ph: (281) 487-0700 |
News Archive
Manhattan Pharmaceuticals, Inc. announced that on January 4, 2011, the company entered into a settlement and release agreement with Nordic Biotech Fund II K/S and H Pharmaceuticals K/S. Manhattan Pharmaceuticals and Nordic are partners in the H Pharmaceuticals joint venture for the development and commercialization of Hedrin®, a non-pesticide treatment for head lice.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
"More than 435,000 people have been displaced in Mali, as the country faces a complex humanitarian emergency due to conflict and food insecurity, according to a new report released by the United Nations relief agency," the U.N. News Centre reports.
People with severe stomach disorders can sometimes suffer from chronic vomiting. This symptom can be treated with electrical impulses from a pacemaker in the stomach. A new method enables patients who could benefit from this treatment to be identified, and electrical stimulation leads to reduced nausea and fewer days in hospital, shows a study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
"To E or not to E," a question prompted by a controversial analysis released last week, is addressed by leading researchers and physicians who recommend that Americans keep taking vitamin E supplements in recommended amounts for overall health benefits.
› Verified 9 days ago
Lan Nguyen, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 4600 E Sam Houston Pkwy S, Pasadena, TX 77505 Phone: 281-487-0700 | |
Mr. Stephen Michael Evankovich, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 4600 E Sam Houston Pkwy S, Pasadena, TX 77505 Phone: 281-487-0700 |